Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy.
Jillian A MoranDaniel L AdamsMartin J EdelmanPablo LopezJianzhong HeYawei QiaoTing XuZhongxing LiaoKirby P GardnerCha-Mei TangSteven Hsesheng LinPublished in: JCO precision oncology (2022)
Blood-based monitoring of dynamic changes in PD-L1 in TACs appears to identify patients with rmNSCLC who may benefit from ICI.